Holiday Research - US competitive landscape and pan-cancer detection, page-19

@josiejow37

First of all thanks for the link as most post do "WODO" without giving links.

Now, remaining comment:

Why did RHY not submitted their FDA application straightaway if someone like you who has purely created profile to talk about RHY (lol )...... no verified username, educational qualification verified to say you are competent to make assessment of any sort including interpreting CMS report .... can confirm "Reading through the above criteria, with Colostat in mind, it does seem to meet them all " ???

Also to your escape word like "perhaps to one" (obviously you will use it to say i did warn ... lol ) ...I ask simple question - why didn't so many smart scientist of RHY .... who were working for over decade didn't identify how big trial required prior to finishing up phase 7 ???

I suggest you should elaborate to everyone why and how you come to below conclusion and which part of the report explicitly say that ?



the real conclusion report provide about rejection for Epi Procolon from report is below : (Screenshot from report not my wording)



reading CMS report and interpreting is not a task for hobbyist who love reading books and that is why it is better be interpreted by experts and if anyone has any doubt then contact RHY with query instead of depending upon other forum in my opinion.